Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial
NCT07500935 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-05-06
Summary
The goal of this clinical trial is to evaluate local and systemic factors involved in palatal mucosal healing after Free Gingival Graft harvest in diabetic patients and to compare them with those in non-diabetic patients.
Diabetic and non-diabetic volunteers of both sexes aged ≥ 18 years with gingival recession may participate. The main questions it aims to answer are:
1. If the palatal wound healing (area of the wound) and percentage of wound epithelialization are different in diabetics compared to non-diabetics.
2. If different factors, such as the oral microbiome, inflammatory markers, and others, are associated with the clinical outcome.
Participants will be asked:
* Receive the procedure to treat their gingival recession defects
* To attend follow-up visits at 7, 14, 30, and 90 days after treatment.
* To provide different biological samples
* To answer different questionnaires.
Conditions
- Diabetes Mellitus
- Gingival Recession, Generalized
- Gingival Recession, Localized
Interventions
- PROCEDURE
-
Free gingival graft
Volunteers with gingival recession will be treated with coronally advanced flap and connective tissue graft (CTG). The CTG will be obtained by harvesting a 2-mm thick free gingival graft (FGG), measuring 15 × 5 mm from the palatal area between the distal of the canine and the mesial aspect of the first molar. The palatal wound will be evaluated.
Sponsors & Collaborators
-
Mauro Santamaria
lead OTHER
Principal Investigators
-
Mauro Pedrine Santamaria, DDS, Ms, PhD · University of Kentucky
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2029-04-30
- Completion
- 2030-04-30
Countries
- United States
Study Locations
More Related Trials
-
Wound Edge Changes Following Treatment With Santyl
NCT01197898 ·Status: COMPLETED ·Phase: PHASE4
-
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
NCT03547635 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
NCT01629199 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease
NCT06952998 ·Status: RECRUITING ·Phase: PHASE4
-
Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers
NCT05095389 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
NCT02667327 ·Status: TERMINATED ·Phase: PHASE3
-
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
NCT02657876 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Topical Human FGF-1 for Wound Healing
NCT00916292 ·Status: UNKNOWN ·Phase: PHASE1
-
Using Santyl on Diabetic Foot Ulcers
NCT01408277 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
NCT00740922 ·Status: COMPLETED
-
Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
NCT04134143 ·Status: TERMINATED ·Phase: PHASE1
-
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01830348 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of ABSOLVE in Diabetic Foot Ulcers
NCT03037970 ·Status: UNKNOWN ·Phase: PHASE2
-
Application of Platelet-Rich Fibrin on Diabetic Foot Wound
NCT05483777 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
NCT01831804 ·Status: COMPLETED ·Phase: PHASE1
-
Santyl vs. Sharp Debridement of Diabetic Foot Wounds
NCT01056198 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
NCT00658957 ·Status: TERMINATED ·Phase: PHASE2
-
Plasma and Scarring of Diabetic Ulcers
NCT04145154 ·Status: COMPLETED ·Phase: NA
-
Macrophage Stimulating Factor in the Treatment of Diabetic Wounds
NCT06608303 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
NCT05243368 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
NCT00351767 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers
NCT05519501 ·Status: COMPLETED ·Phase: NA
-
Shockwave Treatment of Diabetic Foot Ulcer: Step I
NCT00954343 ·Status: WITHDRAWN ·Phase: NA
-
PRP Use in Diabetic Patients Undergoing Cesarean Section
NCT03602950 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
NCT02071979 ·Status: TERMINATED ·Phase: NA